Clarivate shares fall 6% on revenue miss despite earnings beat
Clarivate (CLVT) reported Q3 earnings of $0.21 per share, beating estimates, but revenue of $481.6M missed expectations. Shares fell 6.63% premarket. Q4 guidance was mixed, with EPS matching estimates but revenue below. The company expects fiscal 2026 revenue of $1.97B, below consensus. Organic revenue grew 0.4% YoY, and adjusted EBITDA declined 1.8%.
How this was made
The 30-second read
Why it matters
The revenue shortfall and below‑consensus guidance suggest near‑term downside, though the EPS beat and cash from a recent divestiture provide some upside potential.
Market read
The earnings release is the primary catalyst for CLVT's price movement, making it a high‑impact trading event.
What to watch
The $488.4 M cash from the Life Sciences divestiture may support near‑term liquidity and fund future initiatives.
Background
Clarivate reported Q3 earnings that beat EPS expectations but missed revenue, followed by a 6% pre‑market decline.
Ticker impact
Shares fell 6.6% pre‑market after Q3 revenue missed expectations and guidance was below consensus.
downward pressure as market prices in the revenue shortfall and lower outlook
The earnings release disclosed a 9.2% revenue decline and guidance below consensus, which historically triggers sell‑offs.
Market effects
Intelligence and data‑analytics sector may see broader scrutiny on revenue growth expectations.
European markets could see modest weakness in related tech stocks.
Limited to investors tracking US‑listed information services firms.
Counterpoint
If the market overreacts to the miss, the stock could rebound on the earnings beat and cash from the divestiture.
Key entities
- companyClarivate Plc
Global intelligence provider listed on NYSE under CLVT.
